Chlamydia trachomatis is the most often reported sexually transmitted infection (STI) in the United States with more than 1.4 million cases in 2012, according to a recent report from the Centers for Disease Control and Prevention.Karen Bardossi...
Interpretation of 2021 CDC guidelines on the diagnosis and treatment of Mycoplasma genitalium LENG Xinying1, ZOU Huachun2, FU Leiwen2, KE Wujian1 Author information + 文章历史 + 摘要 生殖支原体是一种与非淋菌性尿道炎、盆腔炎和其他泌尿生殖系统感染风险增加有关的性传播病原体。如果不及时治疗,...
Individuals seen by clinicians in a private health care setting were less likely to receive CDC recommended treatment than those seen in a public health clinic. Males,younger patients, individuals identifying as Black or multiracial, people with HIV, and those with both chlamydia and gonorrhea, all...
Earlier this week, the Centers for Disease Control and Prevention (CDC)published a draft guidancefor the use of doxycycline, a common antibiotic, as a post-exposure prophylaxis (PEP) treatment to prevent sexually transmitted infections (STIs) in individuals who have had unprotected sex. While t...
The 2021 Centers for Disease Control and Prevention STI guidelines provide several updated, evidence-based testing and treatment recommendations. The recommended treatment for gonorrhea is ceftriaxone monotherapy given intramuscularly, with dosing based on the patient's body weight. For chlamydia, ...
If the draft recommendation is adopted, Doxy-PEP would be recommended for gay andbisexual men; other men who have sex with men; andtransgender womenwho have been diagnosed with at least one STI caused by bacteria in the past year. Those infections include gonorrhea, chlamydia or syphilis. ...
The CDC's final tally for 2022 comes as health officials are warning that 2023's case counts of sexually transmitted infections could be worse, in the wake of funding cuts and shortages of a key treatment. "The CDC's latest STI data shows that our nation is facing a rapidly deteriorating...
with black (vs. white) race (aRR = 4.29, 95% CI = 1.14–16.16) and rectal (vs. urogenital) infection (aRR = 5.42, 95% CI = 0.99–29.55), but not treatment regimen.ConclusionThere were no differences in persistent/recurrent urogenital chlamydia infections at six months by treatment type....